Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bone density, microarchitecture and tissue quality after 1 year of treatment with dolutegravir/abacavir/lamivudine.

Autor: Soldado-Folgado J; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Lerma-Chippirraz E; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., Arrieta-Aldea I; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., Bujosa D; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., García-Giralt N; Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, Barcelona, Catalonia, Spain., Pineda-Moncusi M; Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, Barcelona, Catalonia, Spain., Trenchs-Rodríguez M; ABS Passeig de Sant Joan, Institut Català de la Salut, Barcelona, Spain., Villar-García J; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., González-Mena A; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., Díez-Pérez A; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Brown TT; Department of Endocrinology, Johns Hopkins School of Medicine, Baltimore, MA, USA., Knobel H; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain., Güerri-Fernández R; Infectious Diseases Department, Hospital del Mar, Barcelona, Spain.; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.; Musculoskeletal Research Group, IMIM (Hospital del Mar Medical Research Institute), Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, Barcelona, Catalonia, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Oct 01; Vol. 75 (10), pp. 2998-3003.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.

Autor: Güerri-Fernández R; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM.; Department of Medicine, Universitat Autònoma de Barcelona., Lerma-Chippirraz E; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM.; Department of Medicine, Universitat Autònoma de Barcelona., Fernandez Marron A; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., García-Giralt N; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., Villar-García J; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., Soldado-Folgado J; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., González-Mena A; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., Trenchs-Rodríguez M; Catalan Institute of Health (ICS), Barcelona, Spain., Guelar A; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM., Díez-Pérez A; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM.; Department of Medicine, Universitat Autònoma de Barcelona., Brown TT; Department of Endocrinology, Johns Hopkins School of Medicine, Baltimore, Massachusetts, USA., Knobel H; Department of Infectious Diseases, Hospital del Mar Research Institute, IMIM.; Department of Medicine, Universitat Autònoma de Barcelona.

Publikováno v: AIDS (London, England) [AIDS] 2018 Apr 24; Vol. 32 (7), pp. 913-920.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection.

Autor: Lerma-Chippirraz E; Hospital del Mar, Infectious Diseases, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Güerri-Fernández R; Hospital del Mar, Infectious Diseases, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Villar García J; Hospital del Mar, Infectious Diseases, Barcelona, Spain., González Mena A; Hospital del Mar, Infectious Diseases, Barcelona, Spain., Guelar Grinberg A; Hospital del Mar, Infectious Diseases, Barcelona, Spain., Montero MM; Hospital del Mar, Infectious Diseases, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Sorli L; Hospital del Mar, Infectious Diseases, Barcelona, Spain., Calzado S; Hospital del Mar, Infectious Diseases, Barcelona, Spain., Horcajada JP; Hospital del Mar, Infectious Diseases, Barcelona, Spain., Díez-Pérez A; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; Hospital del Mar, Internal Medicine, Barcelona, Spain., Knobel Freud H; Hospital del Mar, Infectious Diseases, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: AIDS research and treatment [AIDS Res Treat] 2016; Vol. 2016, pp. 5120831. Date of Electronic Publication: 2016 Sep 06.